CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Genoptix, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Genoptix, Inc.
1811 Aston Ave.
Phone: (760) 268-6200p:760 268-6200 Carlsbad, CA  92008  United States Fax: (760) 268-6201f:760 268-6201
This company was Merged or Acquired on 12/10/2018.
This company ceased filing statements with the SEC on 3/7/2011.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Genoptix, Inc. is a specialized laboratory service provider focused on delivering personalized and diagnostic services to community-based hematologists and oncologists (hem/oncs). The Company’s service offerings, COMPASSSM and CHART, are designed to meet the specific needs of community-based hem/oncs. Its COMPASS service offering includes the determination by its hempaths of the appropriate diagnostic tests to be conducted and the performance of these tests. The Company’s CHART service offering combines multiple COMPASS assessments and analyses of disease progression after intervening clinical action, providing the hem/onc with a valuable diagnostic tool to track both a patient’s disease and response to the hem/onc’s prescribed treatment regimen over time.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201012/31/2009YesYes--Yes

Industries
SIC Code Description
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer Tina S.Nova 56 2/28/2011 3/1/2000
Chief Financial Officer, Senior Vice President Douglas A.Schuling 49 4/1/1999 4/1/1999
Chief Operating Officer, Executive Vice President Samuel D.Riccitelli 51 10/1/2001 10/1/2001
6 additional Officers and Directors records available in full report.

General Information
Stock Exchange: NASD
Federal Tax Id: 330840570
Fax Number: (760) 268-6201
Email Address: info@genoptix.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023